These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 10330296

  • 21. Diabetogenic T cells are primed both in pancreatic and gut-associated lymph nodes in NOD mice.
    Jaakkola I, Jalkanen S, Hänninen A.
    Eur J Immunol; 2003 Dec; 33(12):3255-64. PubMed ID: 14635033
    [Abstract] [Full Text] [Related]

  • 22. Regulation of type 1 diabetes by a self-MHC class II peptide: role of transforming growth factor beta (TGF-beta).
    Mukherjee R, Chaturvedi P, Agrawal B, Singh B.
    Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):159-69. PubMed ID: 12887099
    [Abstract] [Full Text] [Related]

  • 23. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
    Lo J, Peng RH, Barker T, Xia CQ, Clare-Salzler MJ.
    Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
    [Abstract] [Full Text] [Related]

  • 24. Antigen based therapies to prevent diabetes in NOD mice.
    Ramiya VK, Shang XZ, Pharis PG, Wasserfall CH, Stabler TV, Muir AB, Schatz DA, Maclaren NK.
    J Autoimmun; 1996 Jun; 9(3):349-56. PubMed ID: 8816970
    [Abstract] [Full Text] [Related]

  • 25. Development of an I-Ag7-expressing antigen-presenting cell line: intrinsic molecular defect in compact I-Ag7 dimer generation.
    Nabavieh A, Chou H, Volokhov I, Lee JE, Purdy LE, Elliott JF, Singh B, Madrenas J.
    J Autoimmun; 1998 Feb; 11(1):63-71. PubMed ID: 9480724
    [Abstract] [Full Text] [Related]

  • 26. Immunization of non-obese diabetic (NOD) mice with glutamic acid decarboxylase-derived peptide 524-543 reduces cyclophosphamide-accelerated diabetes.
    Saï P, Rivereau AS, Granier C, Haertlé T, Martignat L.
    Clin Exp Immunol; 1996 Aug; 105(2):330-7. PubMed ID: 8706342
    [Abstract] [Full Text] [Related]

  • 27. Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice.
    Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L.
    J Immunol; 1999 Sep 01; 163(5):2960-8. PubMed ID: 10453045
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. DNA vaccination encoding glutamic acid decarboxylase can enhance insulitis and diabetes in correlation with a specific Th2/3 CD4 T cell response in non-obese diabetic mice.
    Gauvrit A, Debailleul M, Vu AT, Sai P, Bach JM.
    Clin Exp Immunol; 2004 Aug 01; 137(2):253-62. PubMed ID: 15270841
    [Abstract] [Full Text] [Related]

  • 31. Intranasal administration of retinal antigens induces transient T cell activation and apoptosis within drainage lymph nodes but not spleen.
    Laliotou B, Duncan L, Dick AD.
    J Autoimmun; 1999 May 01; 12(3):145-55. PubMed ID: 10222024
    [Abstract] [Full Text] [Related]

  • 32. Islet T cells secreting IFN-gamma in NOD mouse diabetes: arrest by p277 peptide treatment.
    Ablamunits V, Elias D, Reshef T, Cohen IR.
    J Autoimmun; 1998 Feb 01; 11(1):73-81. PubMed ID: 9480725
    [Abstract] [Full Text] [Related]

  • 33. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ, French MB, Chosich N, Harrison LC.
    J Autoimmun; 1994 Oct 01; 7(5):643-53. PubMed ID: 7840856
    [Abstract] [Full Text] [Related]

  • 34. Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes.
    Nikoopour E, Schwartz JA, Huszarik K, Sandrock C, Krougly O, Lee-Chan E, Singh B.
    J Immunol; 2010 May 01; 184(9):4779-88. PubMed ID: 20363968
    [Abstract] [Full Text] [Related]

  • 35. Quantitative thresholds of MHC class II I-E expressed on hemopoietically derived antigen-presenting cells in transgenic NOD/Lt mice determine level of diabetes resistance and indicate mechanism of protection.
    Hanson MS, Cetkovic-Cvrlje M, Ramiya VK, Atkinson MA, Maclaren NK, Singh B, Elliott JF, Serreze DV, Leiter EH.
    J Immunol; 1996 Aug 01; 157(3):1279-87. PubMed ID: 8757636
    [Abstract] [Full Text] [Related]

  • 36. Critical role of IFN-gamma in CFA-mediated protection of NOD mice from diabetes development.
    Mori Y, Kodaka T, Kato T, Kanagawa EM, Kanagawa O.
    Int Immunol; 2009 Nov 01; 21(11):1291-9. PubMed ID: 19778991
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice.
    Mizuno M, Masumura M, Tomi C, Chiba A, Oki S, Yamamura T, Miyake S.
    J Autoimmun; 2004 Dec 01; 23(4):293-300. PubMed ID: 15571923
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.